Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Impact and Evaluation of the Management of Iron Deficiency With or Without Anemia in Patients With Cancer

Trial Profile

Impact and Evaluation of the Management of Iron Deficiency With or Without Anemia in Patients With Cancer

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Sep 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 05 Apr 2022 Primary endpoint (Evaluation of the quality of life of patients with iron deficiency with or without anemia during treatment for their cancer) has been met, according to Results published in the Oncologist.
  • 05 Apr 2022 Results published in the Oncologist
  • 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top